Boston Scientific wins FDA nod for image-guided programming software for deep brain stim
Boston Scientific (NYSE:BSX) announced today that the FDA approved its Vercise Neural Navigator 5 software.
Related Articles
Amae Health is building an in-person approach to mental healthcare in an increasingly digital space | TechCrunch
While many recent mental health-focused startups are digital first, Amae Health focuses on the importance of in-person care.
Amgen Puts Its Weight Behind Obesity Drug With Potential Edge Over Lilly, Novo Nordisk Meds – MedCity News
Amgen is confident its injectable obesity drug would have a differentiated profile compared to medications now on the market from Novo Nordisk and Eli Lilly…
Weight loss drugs and stomach paralysis: New findings
New research shows GLP-1s, a popular diabetes and weight loss treatment, may increase risk of delayed gastric emptying, stomach paralysis, and other GI issues.
Q1 Was Pretty Good For Hospital Finance — But It’s Unclear If It Will Stay That Way – MedCity News
Hospitals’ operating margins and patient volumes dropped slightly in March. While hospitals were doing relatively well financially during the first quarter of the year, this…
NVIDIA integrates its AI microservices with AWS
NVIDIA Healthcare this week announced integration with Amazon Web Services for NIM, its suite of microservices designed to empower foundational models in the realms of…
Trump, Biden admin policy heads agree: Price transparency is here to stay
Price transparency and the No Surprises Act are still in their infancy, but providers and health plans would be smart to comply now to avoid…
Walgreens inks deal with Boehringer Ingelheim to advance clinical trials for obesity treatment
Retail pharmacy giant Walgreens inked another partnership to recruit participants for research as it continues to build out its clinical trials business. | Walgreens has…
Pepper Bio’s ‘Google Maps for Drug Discovery’ Finds Way to Potential New Liver Cancer Drug – MedCity News
Pepper Bio has licensed rights to lerociclib, a molecule that G1 Therapeutics designed to offer dosing and safety advantages over approved therapies in the same…
Novartis Extends Its Reach in Radiopharmaceuticals With $1B Mariana Oncology Acquisition – MedCity News
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big…
GE HealthCare to Unveil AI-enhanced Oncology Solutions at ESTRO 2024 Congress
May 2, 2024 — GE HealthCare has announced a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase…